Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management

• G. Niklas NorénUppsala Monitoring Centre
• Katherine L DoneganMedicines and Healthcare products Regulatory Agency
• Monica A. MuñozUnited States Food and Drug Administration
• Thamir M. AlshammariJazan University
• Nicole L. PrattUniversity of South Australia
• Gianmario CandoreBayer (Germany)
• Daniel R. MoralesEuropean Medicines Agency
• Peter R. RijnbeekErasmus MC
• Andrew BateGlaxoSmithKline (United Kingdom)
• Rodrigo PostigoEuropean Medicines Agency
• Sengwee TohHarvard University
• Gianluca TrifiròUniversity of Verona
• Montse Soriano‐GabarróBayer (Germany)
• Alison C. CaveMedicines and Healthcare products Regulatory Agency
• Patrick B. Ryan